News for 'Dr Reddy'

Vet killed by hippo during treatment at Shivamogga zoo

Vet killed by hippo during treatment at Shivamogga zoo

Rediff.com20 Mar 2026

A veterinarian at the Tavarekoppa Lion and Safari Zoo in Shivamogga, India, died after being attacked by a hippopotamus while providing medical care.

Dr Reddy's in SEC list for terrorist state links

Dr Reddy's in SEC list for terrorist state links

Rediff.com30 Jun 2007

The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.

Dr Reddy's to invest Rs 750 cr in two SEZs

Dr Reddy's to invest Rs 750 cr in two SEZs

Rediff.com20 May 2009

Dr Reddy's Laboratories, the second largest drug maker in the country, would invest about Rs 750 crore.

Dr Reddy's US R&D lab is located in...?

Dr Reddy's US R&D lab is located in...?

Rediff.com6 Apr 2004

Take the rediff business quiz and see how much you know about India's pharmaceutical industry.

Dr Reddy's files with US FDA for generic Zofran

Dr Reddy's files with US FDA for generic Zofran

Rediff.com8 May 2003

Indian drugmaker Dr Reddy's Laboratories said on Thursday it had filed an application with the US Food and Drug Administration to market a generic form of GlaxoSmithKline's anti-nausea drug Zofran.\n\n

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

3-member panel to probe gas leak at Dr Reddy's

3-member panel to probe gas leak at Dr Reddy's

Rediff.com24 Dec 2010

A three-member committee, comprising two officials from the Director of Factories and one pharma expert, will probe the gas leak at a production unit of Dr Reddy's Laboratories (DRL). The Director of Factories will appoint a pharma domain expert soon.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

Domestic sales a booster dose for pharma revenues

Domestic sales a booster dose for pharma revenues

Rediff.com19 Jan 2026

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag. Most brokerages forecast a modest 2-4 per cent growth in profit after tax (PAT) for the quarter. Hospitals and diagnostics companies, meanwhile, are likely to post much stronger numbers, with revenues seen growing 20-22 per cent year-on-year (Y-o-Y).

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Rediff.com30 Jul 2014

DRL launched four new products in North America during the previous quarter.

Dr Reddy's ups R&D spend 41% in FY04

Dr Reddy's ups R&D spend 41% in FY04

Rediff.com14 Jul 2004

Dr Reddy's to acquire OctoPlus for euro 27.4 million

Dr Reddy's to acquire OctoPlus for euro 27.4 million

Rediff.com22 Oct 2012

Dr Reddy's has offered a price of 0.52 euro in cash for each OctoPlus share.

Dr Reddys Lab Q3 net at Rs 93.16 cr

Dr Reddys Lab Q3 net at Rs 93.16 cr

Rediff.com28 Jan 2003

Dr Reddys Laboratories Ltd has posted a net profit of Rs 931.60 million for the quarter ended December 31, 2002 as compared to a net profit of Rs 1615.30 million in the quarter ended December 31,2001.

Shivakumar sworn in as Karnataka CM, Siddaramaiah's son joins cabinet

Shivakumar sworn in as Karnataka CM, Siddaramaiah's son joins cabinet

Rediff.com3 Jun 2026

D K Shivakumar has been sworn in as the Chief Minister of Karnataka, with Governor Thaawarchand Gehlot administering the oath of office and secrecy. The ceremony also saw 13 other ministers, including a Deputy CM, taking their oaths, attended by prominent Congress leaders and religious figures.

'Dr Singh wanted to be treated in India, not abroad'

'Dr Singh wanted to be treated in India, not abroad'

Rediff.com28 Dec 2024

"Dr Manmohan Singh, soon after becoming the prime minister, had himself carried a small table for us to have tea comfortably at his Safdarjung Lane residence instead of asking his house help," Dr Srinath Reddy, who was the chairperson of the PM's medical panel, recalled.

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Rediff.com17 Nov 2020

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.

India-centric plans help Dr Reddy's outperform pharma market

India-centric plans help Dr Reddy's outperform pharma market

Rediff.com27 Dec 2019

In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry growth (14.5 per cent).

How Dr Reddy's plans to win the US market

How Dr Reddy's plans to win the US market

Rediff.com17 Mar 2017

The company has launched only 3 new products during 2015 when compared to 14 launches in 2014

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

'INDIA Alliance Is Dead'

'INDIA Alliance Is Dead'

Rediff.com28 May 2026

'Congress needs a positive agenda rather than primarily picking up on two business houses.'

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.

Scorching days, restless nights: India battles intense heatwave

Scorching days, restless nights: India battles intense heatwave

Rediff.com23 May 2026

Several parts of India are experiencing a severe heatwave, with temperatures soaring past 44 degrees Celsius. States are issuing alerts and taking measures to protect people and animals from the extreme conditions.

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Rediff.com30 Jul 2020

Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.

Factors that will guide the markets this week

Factors that will guide the markets this week

Rediff.com20 Oct 2025

Equity market investors would track global trends, foreign fund movement and quarterly earnings in a holiday-shortened week ahead, analysts said. Stock exchanges BSE and NSE will conduct a special Muhurat trading session on Tuesday, October 21.

The 1,164th open letter to Dr Reddy

The 1,164th open letter to Dr Reddy

Rediff.com14 Oct 2003

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

India Launches Robotic Surgery Systems for Battlefield Emergencies

India Launches Robotic Surgery Systems for Battlefield Emergencies

Rediff.com9 Apr 2026

The Union Ministry of Health and Family Welfare has launched indigenous robotic technologies, Project Vimana and Project Operion, designed to perform life-saving surgeries on the battlefield, potentially revolutionising emergency care for injured security personnel.

HUL tops sustainability rankings as India Inc deepens ESG focus

HUL tops sustainability rankings as India Inc deepens ESG focus

Rediff.com19 Feb 2026

Hindustan Unilever (HUL) has topped the Perpetual Capital Hurun India Impact 50 - 2026 list with 53.9 points (on the scale of 0-100), reflecting a strong performance across key sustainable development goals (SDGs), including climate, water, circularity, gender and biodiversity.

Pietersen eyes England coaching role to refine Test approach

Pietersen eyes England coaching role to refine Test approach

Rediff.com8 Mar 2026

Former England captain Kevin Pietersen has expressed his interest in joining the national team's coaching setup, aiming to refine their approach to Test cricket following their Ashes defeat and scrutiny of the 'Bazball' tactics.

Oppn candidate Reddy urges MPs to vote with conscience in VP polls

Oppn candidate Reddy urges MPs to vote with conscience in VP polls

Rediff.com7 Sep 2025

Opposition candidate B Sudershan Reddy appeals to MPs to vote with conscience in the upcoming vice presidential polls, urging them to prioritize the spirit of India and parliamentary traditions over party loyalty.

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

NDA sweeps RS polls as Nitish, Nitin enter Upper House

NDA sweeps RS polls as Nitish, Nitin enter Upper House

Rediff.com17 Mar 2026

The ruling NDA alliance has secured a majority in the Rajya Sabha elections, winning key seats in Bihar, Odisha, and Haryana, while other candidates were elected unopposed across multiple states. The elections were marked by cross-voting allegations and political maneuvering.

Sharad Pawar, Athawale among 26 elected unopposed to RS

Sharad Pawar, Athawale among 26 elected unopposed to RS

Rediff.com10 Mar 2026

The Rajya Sabha elections saw several candidates elected unopposed, including Sharad Pawar and Ramdas Athawale, while Bihar, Odisha, and Haryana prepare for contested elections.

Doctor kills wife by administering anaesthetic drug, arrested

Doctor kills wife by administering anaesthetic drug, arrested

Rediff.com16 Oct 2025

Despite being a doctor, Mahendra allegedly did not perform CPR. She was taken to a nearby hospital, where doctors declared her dead on arrival, Muni Reddy alleged. Postmortem and Forensic Science Laboratory (FSL) reports later confirmed the presence of anaesthetic substances in her organs, police said.

Suspended MPs: 7 Rahul Loyalists, 1 Marxist

Suspended MPs: 7 Rahul Loyalists, 1 Marxist

Rediff.com3 Feb 2026

8 Member of Parliaments were suspended from Lok Sabha for tearing & throwing papers at the Chair till April 2. Uproar started when Rahul Gandhi was barred from citing former Army Chief, General M M Naravane's memoir on 2020 India-China clash. Rediff.com brings you the details of these MPs who were suspended.

We are front-runners in our field: Dr Anji Reddy

We are front-runners in our field: Dr Anji Reddy

Rediff.com21 Jan 2004

I would like to renew our commitment to advancing the frontiers of science in drug discovery, says the chairman of Dr Reddy's Labs.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'

Nifty ends below 8,600, Dr Reddy's Labs falls 5%; FOMC, BoJ meets eyed

Nifty ends below 8,600, Dr Reddy's Labs falls 5%; FOMC, BoJ meets eyed

Rediff.com26 Jul 2016

The S&P BSE Sensex shed 119 points to close at 27,977 and the Nifty50 dropped 45 points to finish at 8,591.